Read the latest news and research breakthroughs happening at the BC Cancer Agency
Your donations support innovative cancer research and compassionate enhancements to patient care.
Participate or donate to a fundraising event to support breakthrough cancer research in BC.
See how your donations are being used to enable the great work at the BC Cancer Agency to continue.
You are here
Discovery Luncheon - Kelowna
6th Annual Discovery Luncheon
Wednesday, November 9, 2016
Where: Coast Capri Hotel in Kelowna
When: 11:30am (registration) and 12:00pm - 1:15pm (event)
Tickets: $65/each or $520 for a table of 8 (30 tables available)
This is a pivotal time in the history of cancer. With the knowledge that has been gained in the last decade, our opportunity to achieve a world free from cancer has never been more real.
The BC Cancer Foundation was pleased to present the 6th Annual Discovery Luncheon, in support of cutting edge research and enhancements to care at the BC Cancer Agency Sindi Ahluwalia Hawkins Centre for the Southern Interior.
Over the last five years, the Discovery Luncheon has raised $500,000 to support four groundbreaking programs at the BC Cancer Agency in Kelowna.
In each area supported by the Discovery Luncheon, BC Cancer Agency researchers have made huge strides:
- HDR brachytherapy “boost” (implanted radiation in addition to standard external beam radiation) has become standard treatment for patients with high-tier intermediate and high-risk prostate cancer. It is now possible to perform three HDR procedures in a standard operating day, an achievement seen as impossible just a short time ago;
- A pilot program is underway to determine the proportion of patients eligible for breast seed brachytherapy, improve the technique, adapt it for different breast sizes and tumour locations and incorporate new 3D ultrasound technology;
- The PREDICT (Personal REsponse Determinants in Cancer Therapy) is now more than half-way to its goal of 20,000 participants, which will enable large-scale cancer and genomic research across many tumour types;
- More than 20 clinical trials are currently underway including breast, prostate, lung, bladder and lymphoid cancer.
PARTNERS IN DISOVERY SPONSORS